House Oversight Subcommittee hearing on alleged FDA retaliation tentatively set for July 25.
Executive Summary
HOUSE OVERSIGHT SUBCOMMITTEE HEARING ON PERCEIVED FDA RETALIATION is tentatively set for July 25. The hearing will focus on the belief that an adversarial relationship exists between the FDA and the companies it regulates, with particular emphasis on allegations that the agency retaliates against its critics.